2005
DOI: 10.1097/01.pcc.0000163282.63992.13
|View full text |Cite
|
Sign up to set email alerts
|

Hemolytic characteristics of three commercially available centrifugal blood pumps

Abstract: These data are encouraging for the development of a low-prime, mobile neonatal extracorporeal membrane oxygenation circuit using centrifugal pump technology.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
46
1
2

Year Published

2007
2007
2020
2020

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 93 publications
(50 citation statements)
references
References 22 publications
1
46
1
2
Order By: Relevance
“…In comparison with traditional roller pumps, the centrifugal pump has virtually no risk of tubing rupture or spallation; it has a smaller priming volume, it does not require the use of a reservoir, and the new generation of centrifugal pumps have an equivalent incidence of hemolysis. 17 Several large series now report survival of Ͼ50% for VV ECMO in acute, severe respiratory failure. 18,19 Currently, there are no randomized, controlled trials to support the use of the new ECMO circuits in the management of severe, acute respiratory failure, but such a trial (the CESAR trial) is nearing completion in the UK.…”
Section: Discussionmentioning
confidence: 98%
“…In comparison with traditional roller pumps, the centrifugal pump has virtually no risk of tubing rupture or spallation; it has a smaller priming volume, it does not require the use of a reservoir, and the new generation of centrifugal pumps have an equivalent incidence of hemolysis. 17 Several large series now report survival of Ͼ50% for VV ECMO in acute, severe respiratory failure. 18,19 Currently, there are no randomized, controlled trials to support the use of the new ECMO circuits in the management of severe, acute respiratory failure, but such a trial (the CESAR trial) is nearing completion in the UK.…”
Section: Discussionmentioning
confidence: 98%
“…19,20 However, prudence dictates that in view of the much higher incidence of dangerous hemolysis using the centrifugal pump (59 versus 11%), attempts be made to design a pump to use less volume, to be less occlusive and to be more compact. Our in vitro testing model might be useful in comparing new pump designs especially if the difference in hemolysis caused by centrifugal versus roller pumps could be established in vitro as standards of comparison.…”
Section: Discussionmentioning
confidence: 99%
“…However, there have been significant advances in perfusion technology since then; polymethylpentene oxygenators [13,14] and centrifugal pumps [15,16] are capable of several weeks of continuous operation with a low incidence of haemolysis, while heparin-coated circuit components cause less systemic inflammation [17,18] and require lower levels of systemic anticoagulation than non-coated circuits.…”
Section: Ecmo and Ardsmentioning
confidence: 99%